|
Our Life Sciences & Health Care industry specialists provide extensive knowledge and experience on a range of current issues. Growing customer needs, revolution in R&D and drug discovery, shifting markets and sources, evolution of the biotech sector, emergence of specialty and generic sectors, worldwide efforts to control healthcare costs and an evolving regulatory and compliance environment create both opportunities and challenges for life sciences companies.
 |
|
Innovation in Life Industry
Bob Go, Global Managing Director of Deloitte’s Life Sciences and Health Care Industry Group presented two papers at the 2007 World Economic Forum annual meeting. These papers examine innovation in the sector, including key trends and the opinions of top life sciences executives.
|
More
|